Related Experiment Videos
Vasopressin and hypertension in man
Journal of Cardiovascular Pharmacology
|January 1, 1986
Summary
Vasopressin levels are typically lower in common hypertension but elevated in malignant hypertension. However, these elevated vasopressin levels do not significantly contribute to high blood pressure in hypertensive patients.
Area of Science:
- Endocrinology
- Nephrology
- Cardiovascular Medicine
Background:
- Vasopressin, also known as antidiuretic hormone (ADH), plays a role in regulating blood pressure and fluid balance.
- Its precise role in various forms of human hypertension remains incompletely understood.
Purpose of the Study:
- To investigate the association between circulating vasopressin levels and different types of human hypertension.
- To determine if increased vasopressin levels or sensitivity contribute to elevated blood pressure in hypertensive individuals.
Main Methods:
- Measured plasma vasopressin concentrations in patients with primary hyperaldosteronism, benign essential hypertension, malignant-phase hypertension, and normotensive controls.
- Administered vasopressin infusions to normotensive subjects and patients with essential hypertension to assess pressor sensitivity.
- Examined blood pressure in patients with syndrome of inappropriate ADH excess due to bronchogenic carcinoma, who have chronically elevated vasopressin.
Main Results:
- Circulating vasopressin was lower in primary hyperaldosteronism and benign essential hypertension compared to normotensive subjects.
- Plasma vasopressin levels were significantly increased in malignant-phase hypertension.
- Exogenous vasopressin infusion at levels found in malignant hypertension did not elevate blood pressure in normotensive subjects.
- Patients with essential hypertension showed a slight increase in vasopressin sensitivity, but not enough to explain their high blood pressure.
- Patients with syndrome of inappropriate ADH excess had chronically elevated vasopressin but normal blood pressure.
Conclusions:
- Elevated vasopressin in malignant hypertension is likely a consequence of renal salt and water loss, rather than a cause of the hypertension.
- Vasopressin does not appear to be a significant contributor to the elevated blood pressure in most forms of human hypertension studied.
- Increased pressor sensitivity to vasopressin in hypertension is minimal and insufficient to account for the observed blood pressure elevations.